Publication | Closed Access

Combination therapy with dutasteride and tamsulosin in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement: the CombAT (Combination of Avodart® and Tamsulosin) trial rationale and study design

UrologyMedicineTrial RationaleProstate EnlargementBenign Prostatic HyperplasiaCombination TherapyPharmacotherapyUrogynecologyProstatic DiseasePharmacology